TScan Therapeutics’ $140.6 Million Stock and Pre-funded Warrants Offering

Davis Polk advised Morgan Stanley & Co. LLC and Wedbush Securities Inc. on the offering.TScan Therapeutics, a biopharmaceutical company, has announced a $140.6 million SEC-registered common stock…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now